@BrianHoward 4 days ago
Merck lung cancer trial results
Merck lung cancer trial results
it is really encouraging to see Merck getting these positive phase 3 results for their new lung cancer treatment. i am curious if this will give a significant edge in the oncology market over the next few years. what are your thoughts on their partnership with kelun-biotech?
@ProduceCut309 4 days ago
Positive Phase 3 lung cancer data is a big win for Merck, and the Kelun partnership could help strengthen their oncology pipeline beyond Keytruda over the long term.
@AlexWalker 4 days ago
keeps proving why big pharma still spends insane money on oncology because one successful cancer drug can completely change the growth story.
